文献速递心脑血管急症

炎症、胆固醇、脂蛋白(a)与美国女性30年心血管结局

Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women.
PubMed 文献 · N Engl J Med · 2024-08-31
一句话结论在初始健康的美国女性中,单次联合检测高敏C反应蛋白、LDL胆固醇和脂蛋白(a)可预测30年心血管事件风险。

该研究在27,939名初始健康的美国女性中基线测量高敏C反应蛋白、LDL胆固醇和脂蛋白(a),随访30年。主要终点为首次主要不良心血管事件(心肌梗死、冠状动脉血运重建、卒中或心血管死亡),共发生3662例。三种生物标志物最高与最低五分位比较的校正风险比分别为1.70(95%CI 1.52–1.90)、1.36(95%CI 1.23–1.52)和1.33(95%CI 1.21–1.47)。三种标志物对总体风险有独立贡献,联合模型风险跨度最大,支持将动脉粥样硬化事件一级预防策略扩展至传统10年风险评估之外。

要点

  • 基线高敏C反应蛋白最高vs最低五分位:主要终点校正HR 1.70(95%CI 1.52–1.90)。
  • 基线LDL胆固醇最高vs最低五分位:主要终点校正HR 1.36(95%CI 1.23–1.52)。
  • 基线脂蛋白(a)最高vs最低五分位:主要终点校正HR 1.33(95%CI 1.21–1.47)。
  • 三种生物标志物对总体风险有独立贡献,联合模型的风险跨度最大。
  • 冠心病和卒中结果与主要终点结果似乎一致。

适用人群与场景

  • 初始健康的美国女性,基线平均年龄54.7岁,随访30年。

研究设计与关键结果

  • 研究类型:前瞻性队列(女性健康研究,ClinicalTrials.gov NCT00000479),基线测量27,939名初始健康美国女性的高敏C反应蛋白、LDL胆固醇和脂蛋白(a),随访30年。
  • 主要终点为首次主要不良心血管事件(心肌梗死、冠状动脉血运重建、卒中或心血管死亡),30年随访期间共发生3662例。
  • 高敏C反应蛋白最高vs最低五分位:主要终点校正HR 1.70(95%CI 1.52–1.90)。
  • LDL胆固醇最高vs最低五分位:主要终点校正HR 1.36(95%CI 1.23–1.52)。
  • 脂蛋白(a)最高vs最低五分位:主要终点校正HR 1.33(95%CI 1.21–1.47)。
  • 冠心病和卒中结果与主要终点结果似乎一致。
  • 每种生物标志物对总体风险有独立贡献;纳入全部三种生物标志物的模型风险跨度最大。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究(女性健康研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些数据支持将动脉粥样硬化事件的一级预防策略扩展至传统10年风险评估之外。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: High-sensitivity C-reactive protein (CRP), low-density lipoprotein (LDL) cholesterol, and lipoprotein(a) levels contribute to 5-year and 10-year predictions of cardiovascular risk and represent distinct pathways for pharmacologic intervention. More information about the usefulness of these biomarkers for predicting cardiovascular risk over longer periods of time in women is needed because early-life intervention represents an important risk-reduction method.

METHODS: We measured high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels at baseline in 27,939 initially healthy U.S. women who were subsequently followed for 30 years. The primary end point was a first major adverse cardiovascular event, which was a composite of myocardial infarction, coronary revascularization, stroke, or death from cardiovascular causes. We calculated the adjusted hazard ratios and 95% confidence intervals across quintiles of each biomarker, along with 30-year cumulative incidence curves adjusted for age and competing risks.

RESULTS: The mean age of the participants at baseline was 54.7 years. During the 30-year follow-up, 3662 first major cardiovascular events occurred. Quintiles of increasing baseline levels of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) all predicted 30-year risks. Covariable-adjusted hazard ratios for the primary end point in a comparison of the top with the bottom quintile were 1.70 (95% confidence interval [CI], 1.52 to 1.90) for high-sensitivity CRP, 1.36 (95% CI, 1.23 to 1.52) for LDL cholesterol, and 1.33 (95% CI, 1.21 to 1.47) for lipoprotein(a). Findings for coronary heart disease and stroke appeared to be consistent with those for the primary end point. Each biomarker showed independent contributions to overall risk. The greatest spread for risk was obtained in models that incorporated all three biomarkers.

CONCLUSIONS: A single combined measure of high-sensitivity CRP, LDL cholesterol, and lipoprotein(a) levels among initially healthy U.S. women was predictive of incident cardiovascular events during a 30-year period. These data support efforts to extend strategies for the primary prevention of atherosclerotic events beyond traditional 10-year estimates of risk. (Funded by the National Institutes of Health; Women's Health Study ClinicalTrials.gov number, NCT00000479.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Ridker PM, Moorthy MV, Cook NR, et al. Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women. N Engl J Med. 2024. PMID: 39216091. doi:10.1056/NEJMoa2405182

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。